Share
Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION)
BLOOD
Jabbour, E; Kantarjian, HM; Saglio, G; Steegmann, JL; Shah, NP; Boque, C; Chuah, C; Pavlovsky, C; Mayer, J; Cortes, J; Baccarani, M; Kim, DW; Bradley-Garelik, MB; Mohamed, H; Wildgust, M; Hochhaus, A, 2014: Early response with dasatinib or imatinib in chronic myeloid leukemia: 3-year follow-up from a randomized phase 3 trial (DASISION). BLOOD 123(4), p. 494 - 500, doi: 10.1182/blood-2013-06-511592
CEITEC authors: